Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
14 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
89/100
Trial Completion Rate
81/100
Pipeline Concentration
22/100
Pipeline Freshness
78/100
Strategic Signals
Activity
Last 14 days
Pilot Study of Hospital GamePlan4Care for Family Caregivers of People With Dementia (CDA 21-143)
Resistive Training Combined With Nutritional Therapy After Stroke
High-dose Testosterone in Men With Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 Deficiency
An Open-label, Multicenter Phase II Study to Compare the Efficacy of Carboplatin as First-line Followed by Second-line Olaparib Versus Olaparib as First-line Followed by Second-line Carboplatin in the Treatment of Patients With Castration Resistant Prostate Cancer Containing Homologous Recombination Deficiency
Improving Implementation of Outpatient Goals of Care Conversations for Veterans With Serious Illness
Pilot Randomized Controlled Trial of the Mobile Intervention for Suicidal Thoughts
Low Intensity Focused Ultrasound for Posttraumatic Stress Disorder
A Patient-centered, System-based Approach to Improve Informed Dialysis Choice and Outcomes in Veterans With CKD
CSP # 585 - Pilot Study: Gulf War Era Cohort and Biorepository
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)